Welcome to Advanced Search

Models

About 40,731 results
Cells

Hepa1-6-hCD47

Strain Name:Hepa1-6-Cd47em1(hCD47)Smoc
Strain State : Construction |  Cat. NO.:NM-GA02-TM02

The endogenous mouse Cd47 gene was replaced by human CD47 gene.

Cells

MC38-hSEMA4D

Strain Name:MC38-Sema4dem1(hSEMA4D)Smoc
Strain State : Validation of target gene expression completed |  Cat. NO.:NM-S13-TM68

The endogenous mouse Sema4d gene was replaced by human SEMA4D gene.

Cells

4T1-hCD47

Strain Name:4T1-Cd47em1(hCD47)Smoc
Strain State : Validation of tumorigenic capacity completed |  Cat. NO.:NM-S07-TM02

The endogenous mouse Cd47 gene was replaced by human CD47 gene.

Cells

HEK293T-hCLDN 18.2

Strain Name:HEK293T-hCLDN 18.2
Strain State : Validation of tumorigenic capacity completed |  Cat. NO.:NM-W04A-TG01

The endogenous mouse Claudin 18.2 gene was replaced by human CLAUDIN 18.2 gene.

Cells

MC38-hPD-L1/hCD47(2)

Strain Name:MC38-Cd274em1(hCD274)SmocCd47em1(hCD47)Smoc
Strain State : Validation of tumorigenic capacity completed |  Cat. NO.:NM-S13-TM28

Humanized cell

The endogenous mouse Cd274/hCd47 gene was replaced by human CD274/hCD47 gene.

Cells

MC38-hCD47-hCLDN18.2-hB7H3

Strain Name:MC38-hCD47-hCLDN18.2-hB7H3
Strain State : Construction completed |  Cat. NO.:NM-S13-TM71

hCD47&hCLDN18.2&hB7H3 gene humanized MC38 cell line

Cells

CT26-OVA(2)

Strain Name:CT26-OVA(2)
Strain State : Validation of target gene expression completed |  Cat. NO.:NM-S24A-TM34

CT26 cell line with OVA gene overexpression

Cells

MC38-hCD47-hCLDN18.2-hB7H4

Strain Name:MC38-hCD47-hCLDN18.2-hB7H4
Strain State : Construction completed |  Cat. NO.:NM-S13-TM72

hCD47&hCLDN18.2&hB7H4 gene humanized MC38 cell line

Cells

MC38-mFgfr2b-RFP

Strain Name:MC38-mFgfr2b-RFP
Strain State : Construction |  Cat. NO.:NM-S13-TG77

MC38 cell line with mFgfr2b gene overexpression

Cells

CT26-hPD-L1/hCLAUDIN 18.2

Strain Name:CT26-hPD-L1/hCLAUDIN 18.2
Strain State : Construction |  Cat. NO.:NMC-230112

PD-L1 and CLAUDIN 18.2 gene humanized CT26 cell line    

Email Back to top